School of Biochemistry and Immunology
Dr Ed Lavelle
Email: lavellee AT tcd.ie
The main research focus of the Adjuvant Research group is the mechanism by which particulate adjuvants modulate innate and adaptive immune responses. In addition, there is a strong focus on translating this work in order to develop novel adjuvants for injectable and mucosal vaccines. The group works closely with a number of Irish Biotech companies and also with big Pharma engaged in vaccine research.
Dr. Ed Lavelle graduated with a BSc in Microbiology from University College Galway in 1990 and a PhD in Immunology from the University of Plymouth in 1994. He carried out postdoctoral research at the University of Nottingham on nano and microparticles as vaccine adjuvants. This was followed by further postdoctoral positions at the Rowett Research Institute and Trinity College Dublin on vaccine adjuvants and immunomodulators. He was appointed as a lecturer in Immunology in 2004 and is a Principal Investigator in the School of Biochemistry and Immunology.